BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Treatment
36 results:

  • 1. In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway.
    Kuttikrishnan S; Masoodi T; Ahmad F; Sher G; Prabhu KS; Mateo JM; Buddenkotte J; El-Elimat T; Oberlies NH; Pearce CJ; Bhat AA; Alali FQ; Steinhoff M; Uddin S
    J Dermatol Sci; 2023 Nov; 112(2):83-91. PubMed ID: 37865581
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis.
    Ollila TA; Taher R; Moku P; Olszewski AJ
    Blood Adv; 2023 Sep; 7(18):5470-5479. PubMed ID: 37459209
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cost-effectiveness analysis of imatinib versus dasatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia when combined with conventional chemotherapy in China.
    Chen M; Liu L; Zhang L; Lin Y; Lu X; Yang H; Ni J
    BMC Health Serv Res; 2023 Jun; 23(1):652. PubMed ID: 37331932
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study.
    Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Øvlisen AK; Glimelius I; Marklund A; Larsen TS; Holte H; Fosså A; Smeland KB; El-Galaly TC; Eloranta S
    Br J Haematol; 2023 Aug; 202(4):785-795. PubMed ID: 37325886
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Single-cell profiling of T cells uncovers a tissue-resident memory-like T-cell subset associated with bidirectional prognosis for B-cell acute lymphoblastic leukemia.
    Lai W; Wang X; Liu L; Xu L; Mao L; Tan J; Zha X; Zhan H; Lei W; Lan Y; Chen G; Li Y; Luo OJ
    Front Immunol; 2022; 13():957436. PubMed ID: 36532049
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk of Lymph Node Metastasis in T1b Gastric Cancer: An International Comprehensive Analysis from the Global Gastric Group (G3) Alliance.
    Vos EL; Nakauchi M; Gönen M; Castellanos JA; Biondi A; Coit DG; Dikken JL; D'ugo D; Hartgrink H; Li P; Nishimura M; Schattner M; Song KY; Tang LH; Uyama I; Vardhana S; Verhoeven RHA; Wijnhoven BPL; Strong VE
    Ann Surg; 2023 Feb; 277(2):e339-e345. PubMed ID: 34913904
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study.
    Lynggaard LS; Rank CU; Hansen SN; Gottschalk Højfeldt S; Henriksen LT; Jarvis KB; Ranta S; Niinimäki R; Harila-Saari A; Wolthers BO; Frandsen TL; Heyman M; Schmiegelow K; Albertsen BK
    Blood Adv; 2022 Jan; 6(1):138-147. PubMed ID: 34625787
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Discovery of Novel Agents on Spindle Assembly Checkpoint to Sensitize Vinorelbine-Induced Mitotic Cell Death Against Human Non-Small Cell Lung Cancers.
    Chang YC; Tseng YL; Leu WJ; Du CM; Jiang YH; Hsu LC; Hsu JL; Hou DR; Guh JH
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764382
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index.
    Due H; Brøndum RF; Young KH; Bøgsted M; Dybkær K
    BMC Cancer; 2020 Mar; 20(1):237. PubMed ID: 32192453
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic lymphoma.
    Dashputre AA; Gatwood KS; Gatwood J
    J Manag Care Spec Pharm; 2020 Feb; 26(2):186-196. PubMed ID: 32011965
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors.
    Yoshimitsu M; Fuji S; Utsunomiya A; Nakano N; Ito A; Ito Y; Miyamoto T; Suehiro Y; Kawakita T; Moriuchi Y; Nakamae H; Kanda Y; Ichinohe T; Fukuda T; Atsuta Y; Kato K;
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):718-722. PubMed ID: 31821886
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia.
    Hijiya N; Zwaan CM; Rizzari C; Foà R; Abbink F; Lancaster D; Landman-Parker J; Millot F; Moppett J; Nelken B; Caterina Putti M; Tian X; Sinclair K; Santanastasio H; Buchbinder A; Kearns P
    Clin Cancer Res; 2020 Feb; 26(4):812-820. PubMed ID: 31676669
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical features and outcomes of ALK rearranged non-small cell lung cancer with primary resistance to crizotinib.
    Ma D; Zhang Y; Xing P; Hao X; Wang M; Wang Y; Shan L; Xin T; Liang H; Du Y; Zhang Z; Liang L; Li J
    Thorac Cancer; 2019 May; 10(5):1213-1219. PubMed ID: 30993895
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Overall Survival Trends and Clinical Characteristics of Plasmacytoma in the United States: A National Cancer Database Analysis.
    Ghiassi-Nejad Z; Ru M; Moshier E; Chang S; Jagannath S; Dharmarajan K
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):310-319. PubMed ID: 30878315
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
    Bromberg JEC; Issa S; Bakunina K; Minnema MC; Seute T; Durian M; Cull G; Schouten HC; Stevens WBC; Zijlstra JM; Baars JW; Nijland M; Mason KD; Beeker A; van den Bent MJ; Beijert M; Gonzales M; de Jong D; Doorduijn JK
    Lancet Oncol; 2019 Feb; 20(2):216-228. PubMed ID: 30630772
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Correlation between pre-treatment serum carcinoembryonic antigen levels and genotypes in a large population of Chinese people with advanced lung adenocarcinoma.
    Liu J; Zhao YQ; Han X; Hu XF; Wu HB; Chen LJ; Song YP
    Intern Med J; 2019 May; 49(5):634-643. PubMed ID: 30379408
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma.
    Thompson CA; Yost KJ; Maurer MJ; Allmer C; Farooq U; Habermann TM; Inwards DJ; Macon WR; Link BK; Rosenthal AC; Cerhan JR
    Hematol Oncol; 2018 Dec; 36(5):749-756. PubMed ID: 29862550
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in lymphoma.
    Grisariu S; Shapira MY; Or R; Avni B
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):272-279. PubMed ID: 29500148
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Philadelphia chromosome-positive acute lymphoblastic leukemia complicated by concomitant Achromobacter xylosoxidans and Corynebacterium striatum bacteremia following allogeneic hematopoietic stem cell transplantation].
    Katayama Y; Kyo K; Iwato K; Okatani T; Imanaka R; Itagaki M; Katsutani S; Asaoku H
    Rinsho Ketsueki; 2017; 58(11):2250-2255. PubMed ID: 29212977
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate
    Blakkisrud J; Holtedahl JE; Løndalen A; Dahle J; Bach-Gansmo T; Holte H; Nygaard S; Kolstad A; Stokke C
    J Nucl Med; 2018 Apr; 59(4):704-710. PubMed ID: 28848035
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 2.